Clinical trial
A Double Blind, Dose Range, Placebo Controlled Study of the Effects of Rostafuroxin vs Placebo in Patients With Stable, Uncomplicated, Essential Hypertension.
NCT00415038 is registered in ClinicalTrials.gov with sigma-tau i.f.r. S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind, Dose Range, Placebo Controlled Study of the Effects of Rostafuroxin vs Placebo in Patients With Stable, Uncomplicated, Essential Hypertension.
- Lead sponsor
- sigma-tau i.f.r. S.p.A.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- August 31, 2007
- Enrollment
- 438 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.